Follow The Filings

BWAY Brainsway Ltd.

Health Care, filed as BRAINSWAY LTD (SPONSORED ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $2.2M
  • 1 reduce

In 2026 Q2 Cathie Wood trimmed Brainsway.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Cathie Wood, Ark Investment Management). Not free-float ownership.

  1. Cathie Wood Reduce 0.01%

Who owns BWAY

Sorted by value, long equity only, as of 2026 Q2.

History
Cathie Wood, Ark Investment Management 0.01%, was 0.02% Reduce −26.4% 142,500 $2.2M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BWAY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BWAY insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Gilad Moiseyev Chief Technology Officer
    Sale
    — 5,000 shares 8.6% of stake
    Traded Jun 15 Filed Jun 22
  2. Yiftach Roth Chief Scientist
    Sale
    — 7,000 shares 0.6% of stake
    Traded Jun 1–2 Filed Jun 3
  3. Rayten Michal Ety Mitrany Director
    Sale
    — 17,980 shares 59% of stake
    Traded May 25–26 Filed May 26

Also filed in the last 12 months, not counted as buying or selling: 3 share withholdings for taxes and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K/A FORM 6-K/A
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
SCHEDULE 13G/A —
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
SCHEDULE 13G/A —
6-K FORM 6-K
SCHEDULE 13G/A —
6-K FORM 6-K
6-K FORM 6-K
SCHEDULE 13G/A —
20-F FORM 20-F
6-K FORM 6-K
SCHEDULE 13G —

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.